The life sciences and biotechnology industries are working to improve human health and quality of life and also making significant advances in animal and plant life sciences. Companies in these industries are faced with a multitude of complex legal issues.
Ice Miller offers a multidisciplinary practice that helps clients deal with these complexities in creative ways and find solutions. Whether it is developing a portfolio of intellectual property assets, or raising capital for research and development, commercialization of ideas, later stage growth or ultimately a public offering or sale transaction, our team approach is valuable for a company that wants to take its ideas and concepts and turn them into products and services that improve people's lives. We are committed to the success of our clients and staying abreast of new legal and scientific developments to help in this success.
Our experience includes working with life science start-ups to help them with seed-stage funding. We have extensive experience with all types of funds (formations and operations); licensings; financings; leveraged buyouts, roll-ups, build-ups, and consolidations; divestitures and exits; and complex litigation on behalf of investors and privately financed companies.
Our experience helps life sciences companies find solutions through legislation and effective regulatory and governmental affairs. Our extensive product liability experience for several Fortune 500 pharmaceutical and medical device companies provides invaluable "lessons learned" to help all clients, startup to multinational, attempt to avoid the problems which lead to litigation or be best positioned should it occur.
And because of our experience, existing clients seek our assistance with cutting edge issues facing the life sciences industry with the advance of genomics, data exchanges, personalized medicine and corresponding privacy and bioethical issues, to name a few.
Our experience, found in over 50 life sciences lawyers and professionals, can help you turn your ideas into success stories.
For your industry, it's more than life science. It's lifeblood.